Adam D. Scheid
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
- Cancer-related molecular mechanisms research 2
- Cancer Genomics and Diagnostics 1
-
- Mitochondrial Function and Pathology 3
- RNA modifications and cancer 2
- Co-authors
- Danny R. Welch (4 shared papers)Thomas C. Beadnell (4 shared papers)Lavakumar Karyampudi (1 shared paper)Keith L. Knutson (1 shared paper)Marshall D. Behrens (1 shared paper)James Krempski (1 shared paper)Kimberly R. Kalli (1 shared paper)Purushottam Lamichhane (1 shared paper)
- Journals
- Cancer Research (2 papers)Cancer and Metastasis Reviews (1 paper)Cancer Immunology Immunotherapy (1 paper)The Journal of Immunology (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Adam D. Scheid
8 papers receiving 328 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 86
- Immunology 111
- Oncology 133
- Molecular Biology 143
- Biotechnology 10
Countries citing papers authored by Adam D. Scheid
This map shows the geographic impact of Adam D. Scheid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam D. Scheid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam D. Scheid more than expected).
Fields of papers citing papers by Adam D. Scheid
This network shows the impact of papers produced by Adam D. Scheid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam D. Scheid. The network helps show where Adam D. Scheid may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam D. Scheid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 120 | |
| 2 | 2020 | 87 | |
| 3 | 2021 | 44 | |
| 4 | 2018 | 34 | |
| 5 | 2018 | 24 | |
| 6 | 2019 | 14 | |
| 7 | 2018 | 4 | |
| 8 | 2015 | 4 |
About Adam D. Scheid
Adam D. Scheid is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Epidemiology, having authored 8 papers that have together received 331 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Genomics and Diagnostics (1 paper) and Mycobacterium research and diagnosis (1 paper). The work is most often cited by research in Cancer Research (86 citations), Immunology (111 citations), Oncology (133 citations), Molecular Biology (143 citations) and Biotechnology (10 citations). Adam D. Scheid has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Danny R. Welch, Thomas C. Beadnell, Lavakumar Karyampudi, Keith L. Knutson, Marshall D. Behrens, James Krempski, Kimberly R. Kalli, Purushottam Lamichhane, Barath Shreeder and Carolyn J. Vivian. Their work appears in journals such as Cancer Research, Cancer and Metastasis Reviews, Cancer Immunology Immunotherapy, The Journal of Immunology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.